Global Animal Drug Compounding Market Size, Share, Trends & Growth Analysis Report 2026-2034
상품코드:1937090
리서치사:Value Market Research
발행일:2026년 02월
페이지 정보:영문 169 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
동물용 의약품 조제 시장 규모는 2025년 31억 달러에서 2034년에는 67억 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 8.93%로 성장할 전망입니다.
동물용 의약품 조제 시장은 맞춤형 동물의료에 대한 수요 증가와 반려동물 및 가축의 만성질환 확산에 따라 괄목할만한 성장세를 보이고 있습니다. 반려동물 양육 인구의 증가와 동물 건강에 대한 인식이 높아짐에 따라, 수의사들은 개별 동물의 특정 요구에 맞는 맞춤형 의약품을 조제 약국에 의뢰하는 경우가 증가하고 있습니다. 이러한 경향은 시판 중인 의약품이 복용량, 제형 또는 맛의 취향에 맞지 않아 적합하지 않은 경우 특히 두드러집니다. 약품 맞춤화 능력은 치료 효과와 복약 순응도를 높이고, 동물용 의약품 조제 시장을 현대 수의학의 중요한 구성요소로 자리매김하고 있습니다.
또한, 제약 기술 및 규제 프레임워크의 발전은 동물용 조제 의약품 시장 성장을 촉진하고 있습니다. 보다 엄격한 품질 기준과 가이드라인을 도입하여 조제 의약품의 안전성, 유효성, 신뢰성을 보장하고 있습니다. 수의학 전문가들이 조제 의약품의 장점에 대한 이해가 높아짐에 따라 시장이 확대되고, 조제 서비스를 진료에 통합하는 수의학 시설이 늘어날 것으로 예상됩니다. 또한, 수의학 분야에서의 원격의료의 보급은 조제 약국이 보다 광범위한 고객층에 도달할 수 있는 새로운 기회를 창출하고 있으며, 원격 상담 및 맞춤형 약품 배송을 가능하게 하고 있습니다.
동물용 의약품 제제 시장에서는 약물의 기호성과 효능을 높이는 새로운 투여 방법 개발에 초점을 맞춘 제제 기술 혁신도 진행되고 있습니다. 향료 첨가, 경피 흡수 시스템, 서방형 제제 도입 등은 조제 약국이 수의학의 진화하는 요구에 대응하기 위한 노력의 한 예일 뿐입니다. 소비자 수요, 기술 발전, 규제적 지원과 함께 시장이 계속 성장하고 있는 가운데, 동물용 조제 의약품의 미래는 동물의 건강과 복지를 보장하고 치료의 질을 향상시킬 수 있을 것으로 기대됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 동물용 의약품 조제 시장 : 동물 유형별
제5장 세계의 동물용 의약품 조제 시장 : 약물 유형별
제6장 세계의 동물용 의약품 조제 시장 : 제형별
제7장 세계의 동물용 의약품 조제 시장 : 유통 채널별
제8장 세계의 동물용 의약품 조제 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSM
영문 목차
영문목차
The Animal Drug Compounding Market size is expected to reach USD 6.70 Billion in 2034 from USD 3.10 Billion (2025) growing at a CAGR of 8.93% during 2026-2034.
The animal drug compounding market is experiencing a notable surge, driven by the increasing demand for personalized veterinary care and the growing prevalence of chronic diseases in pets and livestock. As pet ownership rises and animal health awareness grows, veterinarians are increasingly turning to compounding pharmacies to create tailored medications that meet the specific needs of individual animals. This trend is particularly significant in cases where commercially available drugs may not be suitable due to dosage, formulation, or flavor preferences. The ability to customize medications enhances treatment efficacy and compliance, positioning the animal drug compounding market as a vital component of modern veterinary practice.
Furthermore, advancements in pharmaceutical technology and regulatory frameworks are facilitating the growth of the animal drug compounding market. The introduction of more stringent quality standards and guidelines is ensuring that compounded medications are safe, effective, and reliable. As veterinary professionals become more educated about the benefits of compounded drugs, the market is likely to expand, with an increasing number of veterinary practices incorporating compounding services into their offerings. Additionally, the rise of telemedicine in veterinary care is creating new opportunities for compounding pharmacies to reach a broader clientele, allowing for remote consultations and customized medication delivery.
The animal drug compounding market is also witnessing innovation in formulation techniques, with a focus on developing new delivery methods that enhance the palatability and efficacy of medications. The incorporation of flavoring agents, transdermal delivery systems, and sustained-release formulations are just a few examples of how compounding pharmacies are adapting to meet the evolving needs of veterinary medicine. As the market continues to grow, driven by a combination of consumer demand, technological advancements, and regulatory support, the future of animal drug compounding promises to enhance the quality of care for animals, ensuring their health and well-being.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Animal Type
Companion Animals
Livestock Animals
By Drug Type
Anti-Infective Agents
Anti-Inflammatory Agents
Hormones & Substitutes
CNS Agents
Other Drug Types
By Dosage Form
Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms)
Topical (Ointments, Creams, Gels, Sprays)
Injectable
Other Dosage Forms
By Distribution Channel
Veterinary Hospitals Pharmacies
Compounding Pharmacies
Other Distribution Channels
COMPANIES PROFILED
AVRIO Pharmacy, New Era Pharmacy, NexGen Pharmaceuticals, Pace Pharmacy, SaveWay Compounding Pharmacy, ScriptWorks, SCIRx Pharmacy, Summit Veterinary Pharmacy Ltd, Triangle Compounding Pharmacy, The Pet Apothecary, Veterinary Pharmaceutical Solutions, Veterinary Specialty Pharmacy, Wedgewood Pharmacy
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1 Information Analysis
1.3.2 Market Formulation & Data Visualization
1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
3.4.1 Standards & Compliance
3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints
3.5.3 Market Opportunities
3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis
Chapter 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)
4.1. Market Analysis, Insights and Forecast Animal Type
4.2. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Livestock Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DRUG TYPE 2022-2034 (USD MN)
5.1. Market Analysis, Insights and Forecast Drug Type
5.2. Anti-Infective Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Anti-Inflammatory Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Hormones & Substitutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. CNS Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Other Drug Types Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DOSAGE FORM 2022-2034 (USD MN)
6.1. Market Analysis, Insights and Forecast Dosage Form
6.2. Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms) Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Topical (Ointments, Creams, Gels, Sprays) Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Other Dosage Forms Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
7.1. Market Analysis, Insights and Forecast Distribution Channel
7.2. Veterinary Hospitals Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Compounding Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY REGION 2022-2034(USD MN)
8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.2.1 By Animal Type
8.2.2 By Drug Type
8.2.3 By Dosage Form
8.2.4 By Distribution Channel
8.2.5 United States
8.2.6 Canada
8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.3.1 By Animal Type
8.3.2 By Drug Type
8.3.3 By Dosage Form
8.3.4 By Distribution Channel
8.3.5 United Kingdom
8.3.6 France
8.3.7 Germany
8.3.8 Italy
8.3.9 Russia
8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.4.1 By Animal Type
8.4.2 By Drug Type
8.4.3 By Dosage Form
8.4.4 By Distribution Channel
8.4.5 India
8.4.6 Japan
8.4.7 South Korea
8.4.8 Australia
8.4.9 South East Asia
8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.5.1 By Animal Type
8.5.2 By Drug Type
8.5.3 By Dosage Form
8.5.4 By Distribution Channel
8.5.5 Brazil
8.5.6 Argentina
8.5.7 Peru
8.5.8 Chile
8.5.9 South East Asia
8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
8.6.1 By Animal Type
8.6.2 By Drug Type
8.6.3 By Dosage Form
8.6.4 By Distribution Channel
8.6.5 Saudi Arabia
8.6.6 UAE
8.6.7 Israel
8.6.8 South Africa
8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL ANIMAL DRUG COMPOUNDING INDUSTRY
